Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Fore Kopi Indonesia Tbk. (FORE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Fore Kopi Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Fore Kopi Indonesia Tbk. trades at Rp830 (market cap 7.58T, 12.59M 24h volume). The key difference: Fore Kopi Indonesia Tbk. is far larger — about 24× Diagnos Laboratorium Utama Tbk.'s market cap, and Fore Kopi Indonesia Tbk. is more actively traded (12.59M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | FORE | |
|---|---|---|
Market Cap | 316.25B | 7.58T |
Volume | 41.7K | 12.59M |
Lot | 417 | 125.87K |
Turnover | 9.66M | 10.69B |
Average Price | 231.65 | 849.66 |
Value | 9.66M | 10.69B |
Indicative Equilibrium Price | 230 | 830 |
Indicative Equilibrium Volume | 2.4K | 1.59K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Fore Kopi Indonesia Tbk.
PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.
Read more on FORE →
